Nursing care
Therapeutic Hypothermia: the nurse's role, start to finish
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Therapeutic hypothermia, also called targeted temperature management, cools a patient to a set target temperature after cardiac arrest to protect the brain from reperfusion injury. Shivering is actively suppressed with sedation and sometimes paralysis, because shivering generates heat and works directly against the cooling the patient needs.
Indications and contraindications
Therapeutic hypothermia, now more often called targeted temperature management, is used after return of spontaneous circulation in patients who remain comatose following cardiac arrest, whether the initial rhythm was shockable or not. The goal is neuroprotection: cooling slows the metabolic and inflammatory cascade that damages neurons in the hours after the brain has been without adequate perfusion.
It is contraindicated, or used with extreme caution, in active uncontrolled bleeding, severe coagulopathy, pre-existing severe hypothermia unrelated to therapeutic intent, and in some protocols in pregnancy or refractory shock where cooling could worsen haemodynamics. Patients who wake and follow commands promptly after arrest generally do not need cooling, since the intervention targets the comatose post-arrest population, not every resuscitated patient.
Getting the patient ready
Confirm the patient meets protocol criteria: comatose, post-ROSC, within the time window the institution specifies. Insert a core temperature probe, oesophageal, bladder, or rectal depending on device and protocol, since surface temperature does not reliably reflect core temperature during active cooling.
Establish continuous cardiac monitoring, as cooling itself can provoke arrhythmias, and secure central or large-bore IV access for cold fluids or medications. Sedation and analgesia are started before or alongside cooling, not after, because the priority intervention this page turns on is shivering suppression: shivering is the body's heat-generating response to cold, and it directly opposes the drop in core temperature the treatment depends on. A neuromuscular blocking agent may be added if sedation alone does not control shivering, in which case continuous EEG monitoring is often used, since paralysis masks seizure activity that post-arrest brains are prone to.
Technique and safety checks
Cooling is delivered by surface pads, cooling blankets, intravascular catheters, or cold IV fluids, and the target temperature and rate of cooling follow the unit's protocol. Reach target temperature promptly and hold it steady for the prescribed duration, monitoring core temperature continuously rather than intermittently, since even small unintended temperature drift undermines the treatment.
Watch potassium closely: cooling shifts potassium intracellularly, so levels fall during induction and rebound during rewarming, and both directions can trigger dysrhythmias if not corrected proactively. Check glucose regularly, as cooling reduces insulin sensitivity and glucose metabolism. Assess skin under cooling pads for frostbite or pressure injury, and reposition per unit protocol despite sedation limiting the patient's own movement.
What can go wrong
Shivering is the complication that undoes the treatment if missed: an inadequately sedated patient shivers to generate heat, raising core temperature and metabolic demand exactly when the brain needs the opposite. Use a validated shivering scale and escalate sedation or add paralysis promptly if shivering breaks through.
Arrhythmias, particularly bradycardia, are expected and usually tolerated unless haemodynamically unstable, since hypothermia itself slows the heart. Coagulopathy and increased bleeding risk accompany cooling, so watch surgical or line sites closely. Infection risk rises because hypothermia blunts the inflammatory response that would otherwise signal it, so a normal white cell count during cooling does not rule out sepsis. Electrolyte swings, especially potassium, and hyperglycaemia both need active correction rather than passive monitoring.
Ongoing care
Maintain the target temperature for the protocol-specified duration, typically with continuous core temperature monitoring, before beginning a controlled, gradual rewarming phase. Rewarming is deliberately slow, often a fraction of a degree per hour, because rapid rewarming causes vasodilation, hypotension, and a rebound rise in potassium as it shifts back out of cells.
Continue neurological assessment once sedation is weaned and the patient is warm, understanding that accurate prognostication is delayed by residual sedative effect and by the cooling itself. Monitor for post-rewarming hyperthermia, which is associated with worse neurological outcome and should be treated promptly. Family communication matters here: outcomes after cardiac arrest and cooling are uncertain in the early days, and setting realistic expectations about the assessment timeline is part of ongoing care.
Common exam questions
NCLEX questions on this topic often test whether you recognise shivering as the priority complication to prevent, and whether you know that sedation, and sometimes paralysis, exists specifically to suppress it rather than purely for comfort. Expect stems asking what to monitor during cooling, with potassium and cardiac rhythm as common correct answers.
Other frequently tested points: the indication is a comatose post-arrest patient, not simply anyone who has been resuscitated; rewarming must be gradual because rapid rewarming causes hypotension and electrolyte rebound; and continuous core temperature monitoring, not skin temperature, guides the intervention throughout.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
Why is shivering a problem during therapeutic hypothermia?
Shivering is the body's mechanism for generating heat, and it directly opposes the cooling the treatment depends on. Left unchecked it raises core temperature, increases metabolic demand and oxygen consumption, and can prevent the patient reaching or holding target temperature, so sedation and sometimes neuromuscular blockade are used specifically to suppress it.
Why does potassium need close monitoring during cooling and rewarming?
Cooling shifts potassium into cells, lowering serum levels during induction, and rewarming shifts it back out, raising levels again. Both directions can precipitate dysrhythmias, so potassium is checked frequently and corrected proactively rather than reactively.
Who should not receive therapeutic hypothermia after cardiac arrest?
Patients who wake and follow commands soon after arrest generally do not need cooling, since the intervention targets the comatose post-ROSC population. Active uncontrolled bleeding, severe coagulopathy, and pre-existing severe hypothermia are relative or absolute contraindications depending on the institution's protocol.
How fast should a patient be rewarmed after therapeutic hypothermia?
Rewarming is deliberately slow and controlled, following the unit's protocol rather than being hurried. Rapid rewarming causes vasodilation, hypotension, and a rebound rise in potassium as it shifts back out of cells, so the process is staged over hours.
Does hypothermia mask signs of infection?
Yes. Hypothermia blunts the inflammatory response, so fever and an elevated white cell count may not appear even when infection is present. Clinical suspicion has to stay high through the cooling phase despite reassuring-looking labs.
More on cardiovascular
Guides on this